Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处的突触后蛋白聚集:从 Dok-7 到 Rapsyn
基本信息
- 批准号:8461165
- 负责人:
- 金额:$ 40.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-15 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgrinBindingBiochemicalBiochemical GeneticsBirthCellsCholinergic ReceptorsComplexCongenital Myasthenic SyndromesCytoskeletonDataDefectDiseaseFailureGenesGeneticHealthHumanIntegral Membrane ProteinIntercellular JunctionsLeadLigandsLinkMaintenanceMass Spectrum AnalysisMediatingMembrane ProteinsMotor NeuronsMovementMusMuscle FatigueMuscle FibersMuscle WeaknessMuscle-Specific KinaseMutationMyastheniaNerveNeurodegenerative DisordersNeuromuscular DiseasesNeurotransmitter ReceptorPTB DomainPathway interactionsPeripheralPhosphorylationPlayPostsynaptic MembraneProceduresProtein BindingProteinsRecruitment ActivityRoleSH3 DomainsSignal PathwaySignal TransductionSkeletal MuscleSynapsesSynaptic TransmissionTyrosineTyrosine PhosphorylationWorkadapter proteinagrin receptorclinically relevantcongenital neuromuscular disorderdesignmutantneuromuscularnovel therapeuticsperipheral membrane protein 43Kpostsynapticprogramsprotein complexprotein functionresearch studyscaffoldsrc Homology Region 2 Domainsynaptogenesis
项目摘要
The Agrin/Lrp4/MuSK/Dok-7 signal transduction cascade is critical for synaptogenesis. Binding between Agrin and Lrp4 stimulates tyrosine phosphorylation of MuSK and recruitment and tyrosine phosphorylation of Dok-7. Hypomorphic mutations in human Agrin, MuSK or Dok-7, which impair their function, cause congenital myasthenia, characterized by structurally and functionally defective synapses, leading to muscle weakness and fatigue, emphasizing the clinical relevance of this signaling pathway. Once phosphorylated, Dok-7 recruits Crk and Crk-L, two related adapter proteins. The Agrin/Lrp4/Dok-7/Crk/Crk-L signaling pathway ultimately intersects with the cytoskeleton to cause accumulation of AChRs and other proteins in the postsynaptic membrane. The experiments in this proposal are designed to reveal the molecules and mechanisms that link recruitment of Crk/Crk-L to the redistribution and anchoring of acetylcholine receptors (AChRs) at developing and adult synapses. The proposed experiments will identify proteins that associate with Rapsyn, an AChR-associated protein that is essential to cluster AChRs, and analyze how these newly identified synaptic proteins, including Vezatin, regulate synaptic differentiation. These studies are clinically relevant, as mutations in Agrin, MuSK, Dok-7 and Rapsyn cause congenital myasthenia, so understanding how these proteins work will contribute to a better understanding of these diseases and may lead to novel therapeutic strategies. Moreover, mutations in genes that are downstream from Crk/Crk-L may likewise cause congenital myasthenia, so identifying the pathway downstream from Crk/Crk-L may reveal new genes responsible for congenital myasthenia.
Agrin/Lrp4/MuSK/Dok-7 信号转导级联对于突触发生至关重要。 Agrin 和 Lrp4 之间的结合刺激 MuSK 的酪氨酸磷酸化以及 Dok-7 的募集和酪氨酸磷酸化。人类 Agrin、MuSK 或 Dok-7 的亚等位突变会损害其功能,导致先天性肌无力,其特征是突触结构和功能缺陷,导致肌肉无力和疲劳,强调了该信号通路的临床相关性。一旦磷酸化,Dok-7 就会招募 Crk 和 Crk-L 这两种相关的衔接蛋白。 Agrin/Lrp4/Dok-7/Crk/Crk-L 信号通路最终与细胞骨架相交,导致 AChR 和其他蛋白质在突触后膜中积累。本提案中的实验旨在揭示将 Crk/Crk-L 募集与发育中和成体突触处乙酰胆碱受体 (AChR) 重新分布和锚定联系起来的分子和机制。拟议的实验将鉴定与 Rapsyn(一种 AChR 相关蛋白,对于 AChR 聚类至关重要)相关的蛋白质,并分析这些新鉴定的突触蛋白(包括 Vezatin)如何调节突触分化。这些研究具有临床意义,因为 Agrin、MuSK、Dok-7 和 Rapsyn 的突变会导致先天性肌无力,因此了解这些蛋白质的工作原理将有助于更好地了解这些疾病,并可能带来新的治疗策略。此外,Crk/Crk-L下游基因的突变同样可能导致先天性肌无力,因此识别Crk/Crk-L下游的通路可能会揭示导致先天性肌无力的新基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Burden其他文献
Steven Burden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Burden', 18)}}的其他基金
THE ROLE OF AGRIN/LRP4/MUSK/DOK-7 SIGNALING IN DISASSEMBLY OF NEUROMUSCULAR SYNAPSES DURING AGING.
AGRIN/LRP4/MUSK/DOK-7 信号在衰老过程中神经肌肉突触分解中的作用。
- 批准号:
9001539 - 财政年份:2015
- 资助金额:
$ 40.77万 - 项目类别:
Development and Homeostasis of Skeletal Muscle in Health and Disease
健康和疾病中骨骼肌的发育和稳态
- 批准号:
8982136 - 财政年份:2015
- 资助金额:
$ 40.77万 - 项目类别:
THE ROLE OF AGRIN/LRP4/MUSK/DOK-7 SIGNALING IN DISASSEMBLY OF NEUROMUSCULAR SYNAPSES DURING AGING.
AGRIN/LRP4/MUSK/DOK-7 信号在衰老过程中神经肌肉突触分解中的作用。
- 批准号:
9145624 - 财政年份:2015
- 资助金额:
$ 40.77万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处突触后蛋白的聚集:从 Dok-7 到 Rapsyn
- 批准号:
8158617 - 财政年份:2011
- 资助金额:
$ 40.77万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn.
神经肌肉突触处突触后蛋白的聚集:从 Dok-7 到 Rapsyn。
- 批准号:
8669301 - 财政年份:2011
- 资助金额:
$ 40.77万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处的突触后蛋白聚集:从 Dok-7 到 Rapsyn
- 批准号:
8658160 - 财政年份:2011
- 资助金额:
$ 40.77万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处突触后蛋白的聚集:从 Dok-7 到 Rapsyn
- 批准号:
8299515 - 财政年份:2011
- 资助金额:
$ 40.77万 - 项目类别:
相似国自然基金
Agrin调控脑微血管周细胞线粒体自噬依赖性铁死亡的分子机制研究
- 批准号:82301501
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
细胞外基质Agrin在脑小血管病类淋巴系统功能障碍中的作用和机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
细胞外基质蛋白Agrin调控肌卫星细胞稳态及其参与老年肌少症发生的机制研究
- 批准号:82260287
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
Agrin在间充质干细胞调控水通道蛋白-4极性分布改善中年HD小鼠脑类淋巴功能中的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Agrin介导再生的皮质脊髓束寻靶支配移植的神经元修复全横断脊髓损伤的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
- 批准号:
10484703 - 财政年份:2022
- 资助金额:
$ 40.77万 - 项目类别:
Entrepreneurial development award for a novel Alzheimer's disease therapeutic
一种新型阿尔茨海默氏病治疗药物获得创业发展奖
- 批准号:
10515571 - 财政年份:2022
- 资助金额:
$ 40.77万 - 项目类别:
Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy
使用基于抗体的疗法促进阿尔茨海默病的成人海马神经发生
- 批准号:
10325833 - 财政年份:2021
- 资助金额:
$ 40.77万 - 项目类别: